CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma

Metastatic skin cutaneous melanoma (SKCM) is a common malignancy that accounts for low morbidity but high mortality of skin cancer. SKCM is characterized by high lymphocytic infiltration, whereas the states of infiltrated cells are variable in patients leading to a heterogeneous prognosis and hinder...

Full description

Bibliographic Details
Main Authors: Jingrun Yang, Yang Xu, Kuixia Xie, Ling Gao, Wenying Zhong, Xinhua Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.991797/full
_version_ 1828142766022983680
author Jingrun Yang
Jingrun Yang
Yang Xu
Kuixia Xie
Ling Gao
Wenying Zhong
Xinhua Liu
Xinhua Liu
author_facet Jingrun Yang
Jingrun Yang
Yang Xu
Kuixia Xie
Ling Gao
Wenying Zhong
Xinhua Liu
Xinhua Liu
author_sort Jingrun Yang
collection DOAJ
description Metastatic skin cutaneous melanoma (SKCM) is a common malignancy that accounts for low morbidity but high mortality of skin cancer. SKCM is characterized by high lymphocytic infiltration, whereas the states of infiltrated cells are variable in patients leading to a heterogeneous prognosis and hindering appropriate clinical decisions. It is therefore urgent to identify markers associated with lymphocytic infiltration, cellular conditions, and the prognosis of SKCM. In this study, we report that CEBPB, a transcriptional factor, is mainly expressed in macrophages in metastatic SKCM and associated with an active tumor immune environment and a favorable prognosis through integrated analysis of single-cell and bulk RNA-seq datasets. High CEBPB expression is significantly associated with active inflammation and immune response pathways in both macrophages and bulk SKCM tumor tissues. A signature based on CEBPB-associated genes that are specifically expressed in macrophages could robustly and prognostically separate different metastatic SKCM patients. In addition, the associations between the metastatic SKCM tumor signature and microenvironment with respect to T-cell recruitment and state, inflammation response, angiogenesis, and so on were also determined. In conclusion, we present here the first report on CEBPB in tumor immune environment and prognosis regulation in metastatic SKCM and construct a reliable signature, which should provide a useful biomarker for stratification of the patient’s prognosis and therapeutic selection.
first_indexed 2024-04-11T19:47:22Z
format Article
id doaj.art-ab4c87b064af471897e3d394313c6a2f
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-11T19:47:22Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-ab4c87b064af471897e3d394313c6a2f2022-12-22T04:06:27ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-10-011310.3389/fimmu.2022.991797991797CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanomaJingrun Yang0Jingrun Yang1Yang Xu2Kuixia Xie3Ling Gao4Wenying Zhong5Xinhua Liu6Xinhua Liu7Department of General Surgery, The First Medical Center of Chinese People’s Liberation Army (PLA) General Hospital, Beijing, ChinaKey Laboratory of Bio-inspired Materials and Interfacial Science, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, ChinaDepartment of Dermatology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, ChinaDepartment of Dermatology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, ChinaKey Laboratory of Aging and Cancer Biology of Zhejiang Province, Hangzhou Normal University, Hangzhou, ChinaMetastatic skin cutaneous melanoma (SKCM) is a common malignancy that accounts for low morbidity but high mortality of skin cancer. SKCM is characterized by high lymphocytic infiltration, whereas the states of infiltrated cells are variable in patients leading to a heterogeneous prognosis and hindering appropriate clinical decisions. It is therefore urgent to identify markers associated with lymphocytic infiltration, cellular conditions, and the prognosis of SKCM. In this study, we report that CEBPB, a transcriptional factor, is mainly expressed in macrophages in metastatic SKCM and associated with an active tumor immune environment and a favorable prognosis through integrated analysis of single-cell and bulk RNA-seq datasets. High CEBPB expression is significantly associated with active inflammation and immune response pathways in both macrophages and bulk SKCM tumor tissues. A signature based on CEBPB-associated genes that are specifically expressed in macrophages could robustly and prognostically separate different metastatic SKCM patients. In addition, the associations between the metastatic SKCM tumor signature and microenvironment with respect to T-cell recruitment and state, inflammation response, angiogenesis, and so on were also determined. In conclusion, we present here the first report on CEBPB in tumor immune environment and prognosis regulation in metastatic SKCM and construct a reliable signature, which should provide a useful biomarker for stratification of the patient’s prognosis and therapeutic selection.https://www.frontiersin.org/articles/10.3389/fimmu.2022.991797/fullCEBPbSKCMtumor immune microenvironmentsingle cell RNAseqimmune subtype
spellingShingle Jingrun Yang
Jingrun Yang
Yang Xu
Kuixia Xie
Ling Gao
Wenying Zhong
Xinhua Liu
Xinhua Liu
CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
Frontiers in Immunology
CEBPb
SKCM
tumor immune microenvironment
single cell RNAseq
immune subtype
title CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
title_full CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
title_fullStr CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
title_full_unstemmed CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
title_short CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
title_sort cebpb is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
topic CEBPb
SKCM
tumor immune microenvironment
single cell RNAseq
immune subtype
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.991797/full
work_keys_str_mv AT jingrunyang cebpbisassociatedwithactivetumorimmuneenvironmentandfavorableprognosisofmetastaticskincutaneousmelanoma
AT jingrunyang cebpbisassociatedwithactivetumorimmuneenvironmentandfavorableprognosisofmetastaticskincutaneousmelanoma
AT yangxu cebpbisassociatedwithactivetumorimmuneenvironmentandfavorableprognosisofmetastaticskincutaneousmelanoma
AT kuixiaxie cebpbisassociatedwithactivetumorimmuneenvironmentandfavorableprognosisofmetastaticskincutaneousmelanoma
AT linggao cebpbisassociatedwithactivetumorimmuneenvironmentandfavorableprognosisofmetastaticskincutaneousmelanoma
AT wenyingzhong cebpbisassociatedwithactivetumorimmuneenvironmentandfavorableprognosisofmetastaticskincutaneousmelanoma
AT xinhualiu cebpbisassociatedwithactivetumorimmuneenvironmentandfavorableprognosisofmetastaticskincutaneousmelanoma
AT xinhualiu cebpbisassociatedwithactivetumorimmuneenvironmentandfavorableprognosisofmetastaticskincutaneousmelanoma